Literature DB >> 9544216

Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparin.

A Leone-Bay1, D R Paton, J Freeman, C Lercara, D O'Toole, D Gschneidner, E Wang, E Harris, C Rosado, T Rivera, A DeVincent, M Tai, F Mercogliano, R Agarwal, H Leipold, R A Baughman.   

Abstract

A family of novel compounds (delivery agents) that promote the gastrointestinal absorption of USP heparin in rats and primates has been discovered. The delivery agents in combination with heparin were administered either orally or intracolonically in an aqueous propylene glycol solution and caused dramatic increases in both plasma heparin concentrations (anti-Factor Xa) and clotting times (APTT). Using one of the most effective delivery agents in this series, an estimated relative bioavailability of 8% can be achieved following oral administration to cynomolgus monkeys. To establish a correlation between the in vivo data and an in vitro parameter, immobilized artificial membrane (IAM) chromatography was performed. Log relative k' values were correlated to the efficiency of oral heparin delivery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544216     DOI: 10.1021/jm970811m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.

Authors:  Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  J Drug Target       Date:  2005-12       Impact factor: 5.121

2.  Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.

Authors:  M Thanou; J C Verhoef; J H Verheijden; H E Junginger
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  Oral delivery of biologically active parathyroid hormone.

Authors:  A Leone-Bay; M Sato; D Paton; A H Hunt; D Sarubbi; M Carozza; J Chou; J McDonough; R A Baughman
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

4.  Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution.

Authors:  Ross W Cheloha; Bingming Chen; Niyanta N Kumar; Tomoyuki Watanabe; Robert G Thorne; Lingjun Li; Thomas J Gardella; Samuel H Gellman
Journal:  J Med Chem       Date:  2017-10-24       Impact factor: 7.446

5.  Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.

Authors:  Constantia E Kast; Davide Guggi; Nina Langoth; Andreas Bernkop-Schnürch
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

6.  Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.

Authors:  Adam W G Alani; Joseph R Robinson
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.